Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NUVL
#916
Nuvalent, Inc. Class A Common Stock
101.950
0
-0.51%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.51%
Changement Mensuel
-3.57%
Evolution sur 6 mois
+7.37%
Changement Annuel
+7.37%
Clôture Précédente
102.470
0
Open
101.950
0
Bid
Ask
Low
101.950
0
High
101.950
0
Volume
98
Marchés
Actions des Marchés US
Soins de Santé
NUVL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
42.88 M
51.27 M
58.63 M
66.16 M
73.18 M
—
Valuation ratios
Enterprise value
2.69 B
4.69 B
14.29 B
4.27 T
5.49 T
18.24 T
Price to earnings ratio
-8.94
-17.56
-35.07
-19.92
-17.19
-64.88
Price to sales ratio
715.11
—
—
—
—
—
Price to cash flow ratio
-10.37
-22.15
-44.42
-28.09
26.57
-41.76
Price to book ratio
1.46
3.11
6.32
4.86
5.86
9.92
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.17
0.17
0.23
0.3
0.38
Return on equity %
0.16
0.18
0.18
0.24
0.34
0.43
Return on invested capital %
7 406.59
11.86 K
15 K
14.8 K
4 493.41
2 817.91
Gross margin %
100
—
—
—
—
—
Operating margin %
7 899.48
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
7 982.76
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
33.07
24.54
22.83
20.96
15.27
54.06
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.84
1.31
1.71
2.79
3.79
3.82
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
13.23
9.51
12.36
16.84
18.87
60.93
Net current asset value per share
13.34
9.62
12.48
17.05
19.16
61.79
Tangible book value per share
13.08
9.32
12.03
16.11
17.17
56.09
Working capital per share
12.94
9.23
11.93
16.24
17.9
57.2
Book value per share
13.08
9.32
12.03
16.11
17.17
56.09
Nouvelles
Nuvalent affiche une perte au T4, attend la décision de la FDA
Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug
Drugmakers turn to AI to speed trials, regulatory submissions
L’action de Nuvalent Inc atteint un sommet de 52 semaines à 112,89 USD
Nuvalent Inc stock hits 52-week high at 112.89 USD
La FDA accepte la demande d’AMM de Nuvalent pour le traitement du CPNPC ROS1-positif
FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment
La directrice juridique de Nuvalent (NUVL) vend des actions pour 676.157€
Nuvalent (NUVL) chief legal officer Miller sells $676k in stock
Nuvalent CSO Pelish sells shares worth $501,752
Nuvalent (NUVL) chief development officer sells $721k in stock
Qu'est-ce qui se passe avec l'action de Royalty Pharma mercredi? | Benzinga France